Advanced Materials & Manufacturing
FMC Corporation
30-Second Executive Brief
Executive Assessment
FMC Corporation functions as a regional institution within Advanced Materials & Manufacturing, backed by 0% sourcing coverage, with accelerating strategic relevance.
- Maintains 2 mapped relationships across the graph
- 0% sourcing coverage across sourced relationships
- Tracked as regional institution within the Advanced Materials & Manufacturing category
Executive Snapshot
- Strategic Role
- Regional Institution
- Sourcing Coverage
- 0%
- Ecosystem Influence
- Moderate
- Strategic Momentum
- Accelerating
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 2
- Technology Domains
- 2
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
FMC Corporation is an American agricultural chemicals company manufacturing herbicides, insecticides, acaricides, and fungicides for global crop protection markets. 2024 revenue was $4.25 billion, with the company reporting a revenue decline into 2025 amid a challenging agricultural chemicals pricing environment.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Additional Intelligence Signals
Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.
Earnings-call mentions
Mentions Corteva
“closing on a licensing agreement for rimisoxafen with Corteva for an upfront payment of $200 million”
SEC 8-K exhibit (0000037785-26-000139) · Jul 29, 2026
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
2 sources
- Company financial aggregation — FMC Corporation revenue trendmarket-data
- StockTitan — FMC Corporation earnings: revenue drops 17%, outlook cutnews
Latest Activity
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding FMC Corporation — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Market Intelligence
UnverifiedCredibly-reported claims — analyst notes, sourcing citing “people familiar with the matter,” deals where the companies involved declined to comment — that haven't been officially confirmed. Kept structurally separate from the sourced evidence above; treat as a lead worth researching further, not an established fact.
Investor reaction (+15.65%) to an earnings beat despite falling revenue suggests the market is pricing in FMC's self-described trough narrative
37% confidenceFMC shares rising 15.65% on a quarter with double-digit revenue decline and a GAAP net loss suggests investors are giving credibility to management's framing of 2026 as a deliberate earnings trough en route to 2027-2028 growth, rather than reading the results as a sign of unresolved structural decline.
This market-reaction interpretation is InsightNodes' own read of the stock's response; the cited source reports the share price move and the trough narrative separately without explicitly linking investor sentiment to acceptance of the trough thesis.
InsightNodes analysis of FMC Q2 2026 results and market reaction · Aug 13, 2026
FMC Corporation's Timeline
A sourced, dated history of FMC Corporation's key moments — founding to present.
Jul 2026 · Q2 2026 results signal 2026 as an earnings trough, targeting ~$1B debt reduction
FMC reported Q2 2026 revenue of $867 million (down amid patent expiration and pricing pressure) with a GAAP net loss of $187 million and adjusted EBITDA of $153 million, though adjusted earnings beat expectations, sending shares up 15.65%. FMC cut full-year 2026 revenue guidance to $3.50-3.70 billion (down 7% at midpoint) and adjusted EBITDA guidance to $620-680 million (down 23% at midpoint), while targeting roughly $1 billion of debt reduction during 2026 and calling 2026 an anticipated earnings trough ahead of growth in 2027-2028.